Format
Sort by

Send to:

Choose Destination

Search results

Items: 4

1.

Childhood Exposures and Risk of Malignancy in Adulthood.

Chang VY, Davidson TB.

Pediatr Ann. 2015 Nov 1;44(11):e270-3. doi: 10.3928/00904481-20151112-10.

PMID:
26587820
2.

PID1 (NYGGF4), a new growth-inhibitory gene in embryonal brain tumors and gliomas.

Erdreich-Epstein A, Robison N, Ren X, Zhou H, Xu J, Davidson TB, Schur M, Gilles FH, Ji L, Malvar J, Shackleford GM, Margol AS, Krieger MD, Judkins AR, Jones DT, Pfister SM, Kool M, Sposto R, Asgharzadeh S.

Clin Cancer Res. 2014 Feb 15;20(4):827-36. doi: 10.1158/1078-0432.CCR-13-2053. Epub 2013 Dec 3. Erratum in: Clin Cancer Res. 2015 Sep 15;21(18):4243. Asgharazadeh, Shahab [corrected to Asgharzadeh, Shahab].

3.

A phase I study of vincristine, irinotecan, temozolomide and bevacizumab (vitb) in pediatric patients with relapsed solid tumors.

Venkatramani R, Malogolowkin M, Davidson TB, May W, Sposto R, Mascarenhas L.

PLoS One. 2013 Jul 22;8(7):e68416. doi: 10.1371/journal.pone.0068416. Print 2013.

4.

Microdeletion del(22)(q12.2) encompassing the facial development-associated gene, MN1 (meningioma 1) in a child with Pierre-Robin sequence (including cleft palate) and neurofibromatosis 2 (NF2): a case report and review of the literature.

Davidson TB, Sanchez-Lara PA, Randolph LM, Krieger MD, Wu SQ, Panigrahy A, Shimada H, Erdreich-Epstein A.

BMC Med Genet. 2012 Mar 22;13:19. doi: 10.1186/1471-2350-13-19. Review.

Format
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk